Natera, Inc. (NASDAQ:NTRA) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Mike Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Alexey Aleshin - GM Oncology, CMO Solomon Moshkevich - President, Clinical Diagnostics John Fesko - President and Chief Business Officer Conference Call Participants Doug Schenkel - Wolfe Research Rachel Vatnsdal - JPMorgan Tejas Savant - Morgan Stanley Tycho Peterson - Jefferies Puneet Souda - Leerink Partners Catherine S ...

Veracyte, Inc. (NASDAQ:VCYT) Q4 2024 Earnings Conference Call February 24, 2025 4:30 PM ET Company Participants Shayla Gorman - Senior Director of Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer Conference Call Participants Doug Schenkel - Wolfe Research, LLC Mason Carrico - Stephens Inc. Puneet Souda - Leerink Partners Maggie Boeye - William Blair & Company Lu Li - UBS Group AG Corey Rosenbaum - Scotiabank Subbu Nambi - Guggenheim Securities, LLC Yuko Ok ...

BeOne Medicines (BGNE) Update / Briefing December 16, 2024 08:30 AM ET Speaker0 Good day, everyone. Welcome to Beijing's Investor Webcast, highlighting key data from the ASH and the San Antonio Breast Cancer Symposium meetings. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session on Beijing's R and D programs and the presented data. At this time, I would like to turn the call over to the company. Speaker1 Hello, and welc ...